Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,350 | -2,880 | 190 | 3,920 | 3,920 |
| Depreciation Amortization | 1,600 | 1,050 | 690 | 1,180 | 1,180 |
| Other Working Capital | -420 | 1,400 | 1,960 | 60 | 60 |
| Other Operating Activity | -5,910 | -2,620 | -2,240 | -2,330 | -2,330 |
| Operating Cash Flow | $-12,080 | $-3,050 | $600 | $2,830 | $2,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,620 | -2,760 | -1,340 | -2,070 | -2,070 |
| Other Investing Activity | 270 | 180 | 130 | 400 | 400 |
| Investing Cash Flow | $-3,350 | $-2,580 | $-1,210 | $-1,670 | $-1,670 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 29,520 | 27,940 | -1,060 | 110 | 110 |
| Financing Cash Flow | $29,520 | $27,940 | $-1,060 | $110 | $110 |
| Exchange Rate Effect | 40 | -630 | -570 | 310 | 310 |
| Beginning Cash Position | 47,450 | 44,610 | 45,570 | 44,650 | 44,650 |
| End Cash Position | 61,580 | 66,280 | 43,330 | 46,250 | 46,250 |
| Net Cash Flow | $14,130 | $21,660 | $-2,240 | $1,600 | $1,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,080 | -3,050 | 600 | 2,830 | 2,830 |
| Free Cash Flow | -12,080 | -3,050 | 600 | 2,830 | 2,830 |